Laboratorios Farmaceuticos Rovi, S.A. (ROVI.MC) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in Spain, listed on MCE. Market cap 2.98B EUR. 52-week range 53.10 to 86.70 EUR. Trailing P/E 16.1. Data as of 2026-10-09.
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It also provides hospital products, such as Iomeron and Iopamiro, Multihance and Y ...